⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Eribulin Versus Vinorelbine in Subjects With Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Eribulin Versus Vinorelbine in Subjects With Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes

Official Title: An Open-label Randomized Parallel Two-arm Multicenter Study of Eribulin Versus Vinorelbine in Female Subjects With Locally Recurrent or Metastatic Breast Cancer, Previously Treated With At Least Two and a Maximum of Five Prior Chemotherapy Regimens, Including an Anthracycline and a Taxane

Study ID: NCT02225470

Study Description

Brief Summary: This study is designed as an open-label randomized parallel two-arm multicenter efficacy, pharmacokinetics and safety study of intravenously administered eribulin versus intravenously administered vinorelbine in Chinese population. Eligible female subjects will have measurable disease according to RECIST 1.1 with the modification that chest x-ray cannot be used for assessment of disease.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: FEMALE

Healthy Volunteers: No

Locations

04 Eisai Trial Site, Bengbu, Anhui, China

37 Eisai Trial Site, Hefei, Anhui, China

01 Eisai Trial Site, Beijing, Beijing, China

03 Eisai Trial Site, Beijing, Beijing, China

33 Eisai Trial Site, Beijing, Beijing, China

35 Eisai Trial Site, Beijing, Beijing, China

07 Eisai Trial Site, Fuzhou, Fujian, China

08 Eisai Trial Site, Fuzhou, Fujian, China

20 Eisai Trial Site, Guangzhou, Guangdong, China

36 Eisai Trial Site, Guangzhou, Guangdong, China

10 Eisai Trial Site, Nanning, Guangxi, China

12 Eisai Trial Site, Shijiazhuang, Hebei, China

11 Eisai Trial Site, Harbin, Heilongjiang, China

38 Eisai Trial Site, Zhengzhou, Henan, China

14 Eisai Trial Site, Wuhan, Hubei, China

15 Eisai Trial Site, Wuhan, Hubei, China

05 Eisai Trial Site, Changsha, Hunan, China

13 Eisai Trial Site, Changsha, Hunan, China

34 Eisai Trial Site, Changsha, Hunan, China

18 Eisai Trial Site, Nanjing, Jiangsu, China

31 Eisai Trial Site, Nanjing, Jiangsu, China

16 Eisai Trial Site, Changchun, Jilin, China

17 Eisai Trial Site, Changchun, Jilin, China

06 Eisai Trial Site, Dalian, Liaoning, China

19 Eisai Trial Site, Shenyang, Liaoning, China

21 Eisai Trial Site, Yinchuang, Ningxia, China

28 Eisai Trial Site, Xi'an, Shaanxi, China

24 Eisai Trial Site, Xian, Shaanxi, China

22 Eisai Trial Site, Qingdao, Shandong, China

09 Eisai Trial Site, Shanghai, Shanghai, China

23 Eisai Trial Site, Taiyuan, Shanxi, China

26 Eisai Trial Site, Chengtu, Sichuan, China

27 Eisai Trial Site, Tianjin, Tianjin, China

30 Eisai Trial Site, Yunnan, Yunnan, China

40 Eisai Trial Site, Hangzhou, Zhejiang, China

Contact Details

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: